Incyte (INCY), Large Cap AI Study of the Week
May 7, 2024
Weekly AI Pick from the S&P 500
Company Overview
Incyte Corporation, a biopharmaceutical company headquartered in Wilmington, Delaware, operates globally with a primary focus on Hematology/Oncology and Inflammation and Autoimmunity. Its flagship product, JAKAFI (ruxolitinib), is a JAK1 and JAK2 inhibitor used to treat